Korro Bio is trading 5.51% down at $9.77 after opening-market weakness on September 23, 2026.
- No new company-specific announcement dated September 23 was identified; the latest listed release was a September 11 inducement grant.
- The broader biotech sector is higher, while major U.S. indexes are modestly lower; neither direction clearly explains the drop.